Document Detail

Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study.
MedLine Citation:
PMID:  21557718     Owner:  NLM     Status:  Publisher    
Abstract Background and aims. Fecal calprotectin (FC) is used as a marker for intestinal inflammation in inflammatory bowel disease (IBD) but there is no reliable marker for collagenous colitis (CC). We have previously demonstrated that the mucosal inflammation in CC is characterized by eosinophil activation, which is restored during budesonide treatment, but there is no enhanced neutrophil activity. The aim of this study was to evaluate the use of fecal eosinophil cationic protein (F-ECP) and eosinophil protein X (F-EPX) compared with the neutrophil-derived myeloperoxidase (F-MPO) and FC in patients treated for active CC. Methods. Patients with active CC (n = 12) were studied before and after 3, 7, 28 and 56 days of budesonide treatment. Clinical symptoms and stool frequency were recorded, fecal samples were collected, and F-ECP, F-EPX, F-MPO and FC were measured at each occasion. Results. All but one patient achieved remission. On inclusion 92%, 67%, 67% and 75% of the patients had elevated F-ECP, F-EPX, F-MPO and FC levels, respectively. All markers decreased during the treatment, particularly F-ECP and F-EPX, which decreased after only 3 days. At the end of the study 100%, 92%, 83% and 75% of the patients had normal F-ECP, F-EPX, F-MPO and FC values, respectively. Conclusion. F-ECP demonstrated the best discriminating capacity in detecting active CC. A normalized F-ECP and F-EPX may further be studied as a marker for successful treatment. During budesonide treatment there is a rapid fall in F-ECP and F-EPX, accompanied by clinical improvement, indicating an essential role for the eosinophil participating in the pathophysiology of CC.
Michael Wagner; Christer G B Peterson; Ingrid Stolt; Per Sangfelt; Margret Agnarsdottir; Maria Lampinen; Marie Carlson
Related Documents :
2494248 - Clinical zinc deficiency during adequate enteral nutrition.
9674788 - Decreased type iv collagen of skin and serum in patients with amyotrophic lateral scler...
21087228 - Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is...
21218608 - C-reactive protein in acute pulmonary embolism.
22652728 - Role of vitamin d receptor activators in peritoneal dialysis.
17601378 - Disease progression, response to acei/atra therapy and influence of ace gene in iga nep...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-11
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  -     ISSN:  1502-7708     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Medical Sciences, Gastroenterology Research Group , Uppsala University, Uppsala , Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fully covered, retrievable self-expanding metal stents (Niti-S) in palliation of malignant dysphagia...
Next Document:  Tolfenamic Acid Interrupts the De Novo Synthesis of the ?-Amyloid Precursor Protein and Lowers Amylo...